Craig Bijou
Stock Analyst at B of A Securities
(3.78)
# 728
Out of 4,983 analysts
63
Total ratings
60%
Success rate
54.5%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Underperform | $18 → $9 | $9.22 | -2.39% | 2 | Jul 9, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $39.43 | +113.04% | 4 | Apr 25, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $126.37 | +10.79% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $15.05 | +12.96% | 3 | Feb 20, 2025 | |
| GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $58.09 | +67.00% | 4 | Jan 9, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $15.00 | +20.00% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $102.56 | +41.38% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $82.79 | +24.41% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $51.03 | +66.57% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $77.60 | +10.82% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $65.12 | +45.88% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $15.20 | +136.84% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $8.59 | +423.86% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $3.98 | +2,915.08% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.79 | +526.30% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $16.81 | -22.67% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $14.92 | +181.50% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $433.36 | -46.93% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $377.93 | -39.14% | 4 | Jul 26, 2019 |
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $9.22
Upside: -2.39%
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $39.43
Upside: +113.04%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $126.37
Upside: +10.79%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $15.05
Upside: +12.96%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $58.09
Upside: +67.00%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $15.00
Upside: +20.00%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $102.56
Upside: +41.38%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $82.79
Upside: +24.41%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $51.03
Upside: +66.57%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $77.60
Upside: +10.82%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $65.12
Upside: +45.88%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $15.20
Upside: +136.84%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $8.59
Upside: +423.86%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $3.98
Upside: +2,915.08%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $4.79
Upside: +526.30%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $16.81
Upside: -22.67%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $14.92
Upside: +181.50%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $433.36
Upside: -46.93%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $377.93
Upside: -39.14%